chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Scan with contrast normal, Troponin normal, Vertigo
Clinical narrative: I received COVID vaccine (Spikevax) late afternoon on 10/13/2023. In addition to my typical reaction to past COVID vaccines (severe chills, presumed fever, severe HA, arthralgia, N/V), I developed severe facial and periorbital edema as well as severe swelling of hands and feet. I have both Cutaneous Mastocytosis and Indolent Systematic Mastocytosis (CM, ISM, both diagnosed in 2023); the rash associated with CM was triggered. Additionally, I had moderate lightheadedness and vertigo as well as hypotension as per home blood pressure monitor. I have two Epipens with me at all times as ISM is associated with a high incidence of anaphylaxis due to mast cell activation but did not use them. Note: ISM is a chronic myeloproliferative neoplasm associated with exceedingly high mast cell burden. Triggers cause degranulation of these mast cells. Typically, ISM is associated with a non-immunologic reaction as opposed to an immunologic IgE-mediated reaction. I had no angioedema, hives, or difficulty breathing which are more commonly associated with the latter. I did not seek treatment at a hospital. Instead, I received IV fluids (3 L D5W or LR) at home for dehydration, treated the N/V with prochlorperazine and ondansetron (not at same time, both prescribed prior to vaccine administration based on history), and maintained my regimen of cetirizine 10 mg TID, cimetidine 200 mg BID, and Singulair 10 mg QD. My symptoms gradually improved over 3 days with the exception of vertigo, dizziness, severe HA, difficulty maintaining balance, and nausea. I sought treatment in the ED on 10/18/2023 for worsening symptoms. I received 1 L LR and an unknown dose of IV ondansetron. I was worked up for a PE and MI. CT with contrast was negative for both); repeat troponin levels and 12-lead ECG were normal. I was subsequently released. (Yes, in hindsight I know I should have self administered epinephrine and sought emergency medical care on 10/14 and/or 10/15/2023).
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: I received COVID vaccine (Spikevax) late afternoon on 10/13/2023. In addition to my typical reaction to past COVID vaccines (severe chills, presumed fever, severe HA, arthralgia, N/V), I developed severe facial and periorbital edema as well as severe swelling of hands and feet. I have both Cutaneous Mastocytosis and Indolent Systematic Mastocytosis (CM, ISM, both diagnosed in 2023); the rash associated with CM was triggered. Additionally, I had moderate lightheadedness and vertigo as well as hypotension as per home blood pressure monitor. I have two Epipens with me at all times as ISM is associated with a high incidence of anaphylaxis due to mast cell activation but did not use them. Note: ISM is a chronic myeloproliferative neoplasm associated with exceedingly high mast cell burden. Triggers cause degranulation of these mast cells. Typically, ISM is associated with a non-immunologic reaction as opposed to an immunologic IgE-mediated reaction. I had no angioedema, hives, or difficulty breathing which are more commonly associated with the latter. I did not seek treatment at a hospital. Instead, I received IV fluids (3 L D5W or LR) at home for dehydration, treated the N/V with prochlorperazine and ondansetron (not at same time, both prescribed prior to vaccine administration based on history), and maintained my regimen of cetirizine 10 mg TID, cimetidine 200 mg BID, and Singulair 10 mg QD. My symptoms gradually improved over 3 days with the exception of vertigo, dizziness, severe HA, difficulty maintaining balance, and nausea. I sought treatment in the ED on 10/18/2023 for worsening symptoms. I received 1 L LR and an unknown dose of IV ondansetron. I was worked up for a PE and MI. CT with contrast was negative for both); repeat troponin levels and 12-lead ECG were normal. I was subsequently released. (Yes, in hindsight I know I should have self administered epinephrine and sought emergency medical care on 10/14 and/or 10/15/2023).
Sex: M
Vaccine: COVID19
Symptoms: Cerebral mass effect, Cerebrovascular accident, Haemorrhagic cerebellar infarction, Magnetic resonance imaging head abnormal
Clinical narrative: I am 46 year old male. I took Pfizer's Covid 19 vaccine n 13-Oct-2023 at 3:30 PM at a store. I had mild brain stroke on 16-Oct-2023 at 6 AM. I was hospitalized for 4 days. I have medical history of high blood pressure. High blood pressure is hereditary on my fathers side.
Sex: U
Vaccine: FLU4, FLU4
Symptoms: Syringe issue, Underdose
Clinical narrative: The product leaks out of the pre-filled syringe during administration to patients
Age: 1.08
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Rash papular, Scab
Clinical narrative: Pt presented to the clinic today with bumpy rash. Pt father states that symptoms began a week ago with bumps on his face that changed to look like pimples. Pt father states that vesicles then spread throughout his  whole body. Pt father states bumps filled with fluid. Pt father states Pt has not been inching or showing pain symptoms. Pt father states that after the vesicles ruptured they scabbed over. Pt father states that Pt condition appears to be improving. Pt father denies using any medication on skin, although Pts mother gave herb baths. Pt father states that Pts sibling is not showing any similar symptoms.  No vesicles currently noted on body, only small scabbed over wounds.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Wrong age group. 12+ was given to this patient that is 11 years old.
Age: 14.0
Sex: F
Vaccine: FLU4, HPV9
Symptoms: Blood glucose normal, Dizziness, Dyspnoea, Haemoglobin normal, Hypotension
Clinical narrative: Syncope, light headedness, shortness of breath, nausea, hypotension. Symptoms resolved within half an hour.
Age: 14.0
Sex: F
Vaccine: FLU4, HPV9
Symptoms: Nausea, Syncope
Clinical narrative: Syncope, light headedness, shortness of breath, nausea, hypotension. Symptoms resolved within half an hour.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: hospitalized 10/28/2023-10/30/2023 for Covid
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort, Feeling abnormal, Tremor
Clinical narrative: Patient received Influenza Vaccine this AM. Vaccine information; Lot #: A, Exp. date: 2024-JUN-30. Patient C/O not feeling good after receiving FLU shot. Observed patient feeling shaky. Two sets of V/S done: at 0650 - BP 236/143 HR 92 T 98.3 O2 Sat 98% RA. Rapid Response called. At 0656 - BP 190/109 HR 78 T 98.3 O2 Sat 100% RA. Patient said she has Hx of high blood pressure, did not take her BP meds today. Patient C/O chest tightness. Transferred to the ER for further monitoring.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood test, Computerised tomogram, Diplopia, Eye disorder, Photopsia
Clinical narrative: OCT 9TH BRIGHT FLASHES OF LIGHTS IN RIGHT EYE, FOLLOWED BY DOUBLE VISION, OCT 11 PT SEEN BY DR. CT SCAN & EXAM DONE. OCT 16TH PT SEEN BY DR. EYE SPECAILIST, BLOOD TEST & EXAM DONE, DX WITH RIGHT EYE 6TH NERVE PALSEY, (STROKE IN EYE). PT SEEN OCT 20 BLOOD TEST DONE & EXAM. PT CONTINUES TO HAVE DOUBLE VISION, OCT 30 PT SEEN BY DR. DOUBLE VISION CONTINUES BUT IS IMPROVING. ALL INFORMATION REPORTED TO ME BY PT.
Age: 74.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: VIth nerve paralysis
Clinical narrative: OCT 9TH BRIGHT FLASHES OF LIGHTS IN RIGHT EYE, FOLLOWED BY DOUBLE VISION, OCT 11 PT SEEN BY DR. CT SCAN & EXAM DONE. OCT 16TH PT SEEN BY DR. EYE SPECAILIST, BLOOD TEST & EXAM DONE, DX WITH RIGHT EYE 6TH NERVE PALSEY, (STROKE IN EYE). PT SEEN OCT 20 BLOOD TEST DONE & EXAM. PT CONTINUES TO HAVE DOUBLE VISION, OCT 30 PT SEEN BY DR. DOUBLE VISION CONTINUES BUT IS IMPROVING. ALL INFORMATION REPORTED TO ME BY PT.
Age: 1.25
Sex: M
Vaccine: DTAP, MMRV
Symptoms: Wrong product administered
Clinical narrative: Patient was due to an MMR & was given MMRV.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous
Clinical narrative: Patient developed a red rash over the shoulder of injection down to the elbow. They did not describe any other symptoms such as itching or flaky skin. Patient did not seek medical attention.
Age: 43.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Inflammation, Musculoskeletal discomfort, Neck pain, Pain
Clinical narrative: After 24 hours, patient felt sharp, throbbing pain, inflammation, hotness, and sharp pain.  The symptoms travelled up the patient's upper shoulder and lower neck area with severe pain and discomfort.
Age: 43.0
Sex: M
Vaccine: FLU4
Symptoms: Skin warm
Clinical narrative: After 24 hours, patient felt sharp, throbbing pain, inflammation, hotness, and sharp pain.  The symptoms travelled up the patient's upper shoulder and lower neck area with severe pain and discomfort.
Age: 63.0
Sex: F
Vaccine: FLUR4, RSV
Symptoms: Condition aggravated, Eczema, Urticaria
Clinical narrative: Patient received flu shot and Arexvy on Saturday and woke up with hives/eczema covering her face Sunday
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: GOT FLUAD IN RIGHT ARM AND COMIRNATY IN LEFT ARM. NEXT MORNING CALLED WITH HIVES DOWN THE LEFT SIDE ONLY AND SURROUNDING THE COMIRNATY SITE.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: The patient received an underdose of the Pfizer COVID vaccine. The patient received the 2023-2024 COVID Pfizer vaccine formulation for those ages 5yo-11yo. The patient should have received the Comirnaty Pfizer COVID vaccine for those 12yo+. Follow up treatment is for patient to receive the correct dose of the Comirnaty Pfizer COVID vaccine for 12yo+. The patients parent has been contacted and given this information to receive the dose they need of the Pfizer COVID vaccine. No poor outcomes occurred, per the patients mother, from the patient receiving the Pfizer COVID vaccine for those ages 5yo-11yo 2023-2024 formulation.
Age: 81.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Blood pressure increased, Decreased appetite, Discomfort, Fatigue, Head discomfort
Clinical narrative: She got her vaccine, there was nothing at all initially.  At 5:00 she started feeling tired and like she started noticing her BP was increasing.  She did not want to eat anything.  She went to bed early and her BP started to rise, she started getting a pressure feeling inside and she can feel it in her whole body and her head.  Was on her side and her heart was beating against the bed.  She tried to take deep breaths and lie there.  At about 2:00 AM it stopped, the full pressure feeling went away and she was OK after that.  She has had feelings of high BP before so she knows what it is like.  She did not take anything for her reaction, was afraid to take anything.    She has left a message with her doctor, but has has not heard back from her.
Age: 81.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Palpitations
Clinical narrative: She got her vaccine, there was nothing at all initially.  At 5:00 she started feeling tired and like she started noticing her BP was increasing.  She did not want to eat anything.  She went to bed early and her BP started to rise, she started getting a pressure feeling inside and she can feel it in her whole body and her head.  Was on her side and her heart was beating against the bed.  She tried to take deep breaths and lie there.  At about 2:00 AM it stopped, the full pressure feeling went away and she was OK after that.  She has had feelings of high BP before so she knows what it is like.  She did not take anything for her reaction, was afraid to take anything.    She has left a message with her doctor, but has has not heard back from her.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Lip swelling, Urticaria
Clinical narrative: Broke out in hives 3 days after 2nd dose. Hives started on left arm then spread to right arm, then all over including face and groin area. Treated in ER with intravenously with Decadron, Benadryl, Pepcid  and sodium chloride.  Released from ER but went back a few hours later when lips began to swell. Given same meds in pill form. I was over an hour away from home and had to wait until later in the day to fill prescription which included Prednisone.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired driving ability, Mobility decreased, Muscular weakness, Pain in extremity
Clinical narrative: I am experiencing in my right hand and arm, muscle weakness and pain. It's difficult to grab something and drive. I have to make sure I am holding the steering wheel with both hands left and right. I am going to the doctor on Friday, November 3rd.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Moderna 12+ 50mcg/0.5ml  (2023/2024) version was given to patient on 10/26/23  at 2:30 pm.  After it was given, on 10/27/23 it was found that the patient receiving the vaccine is 11 years and 7 months old.
Age: 66.0
Sex: M
Vaccine: FLUA4
Symptoms: Arthralgia, Cold sweat, Joint stiffness, Mobility decreased, Musculoskeletal stiffness
Clinical narrative: The next day his joints started hurting all over and he woke up with cold sweats.  His hands also had become swollen  He reports his hand swelling persisted He reports his elbows and shoulders have been stiff and sore. His neck and knees have been painful and stiff is well 10/28 patient still unable to close his hands all the way
Age: 66.0
Sex: M
Vaccine: FLUA4
Symptoms: Peripheral swelling
Clinical narrative: The next day his joints started hurting all over and he woke up with cold sweats.  His hands also had become swollen  He reports his hand swelling persisted He reports his elbows and shoulders have been stiff and sore. His neck and knees have been painful and stiff is well 10/28 patient still unable to close his hands all the way
Age: 67.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Appetite disorder, Dysgeusia, Nausea
Clinical narrative: the day after the shot was given patient had dysgeusia (bad metallic/ medicinal taste in mouth) nausea and change in appetite. these adverse events are still affecting the patient as of the time of reporting.
Age: 67.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Decreased appetite, Dysgeusia, Nausea, Weight decreased
Clinical narrative: the day after the shot was given patient had dysgeusia (bad metallic/ medicinal taste in mouth) nausea and change in appetite. these adverse events are still affecting the patient as of the time of reporting.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Acute motor-sensory axonal neuropathy, Antiacetylcholine receptor antibody, Antibody test negative, Areflexia, Ascending flaccid paralysis
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Asthenia, Autoantibody negative, Borrelia test, Borrelia test negative, CSF glucose increased
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: CSF protein normal, CSF red blood cell count positive, CSF white blood cell count negative, Corneal reflex decreased, Cranial nerve disorder
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Dyspnoea, Electromyogram abnormal, Endotracheal intubation, Guillain-Barre syndrome, HIV test negative
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Hypotonia, Magnetic resonance imaging normal, Mechanical ventilation, Motor neurone disease, Muscular weakness
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Oculocephalogyric reflex absent, Pallor, Paraesthesia, Plasmapheresis, Pupillary reflex impaired
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 73.0
Sex: M
Vaccine: COVID19, RSV
Symptoms: Unresponsive to stimuli
Clinical narrative: Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG.   Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes.   A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.?   A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.?  Multiple other medical conditions being monitored.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Gastrointestinal disorder, Gaze palsy, Muscle spasms, Pain
Clinical narrative: Chills to the point my body was in spasms that would  not stop, high fever, body aches as if hit by a truck, headache, bowels in distress, inability to urinate.  This is my 5th Covid vaccine and although I have a reaction each time, never to this level. Thought I would have to go to ER
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Urinary retention
Clinical narrative: Chills to the point my body was in spasms that would  not stop, high fever, body aches as if hit by a truck, headache, bowels in distress, inability to urinate.  This is my 5th Covid vaccine and although I have a reaction each time, never to this level. Thought I would have to go to ER
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Product administered at inappropriate site
Clinical narrative: Just the flu vaccine via offsite provider- vaccine was given too high per employee in right deltoid and now she cannot lift her arm above shoulder level without pain. Employee states that she felt air compress in her arm at the time of vaccine   I DO NOT KNOW WHICH VACCINE AS I DID NOT ADMINISTER IT. NO LOT NUMBER ETC
Age: 101.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: patient received Covid vaccination senior living facility from us Wednesday 10/25/23.  Unknown o us the patient visited Clinic and received the Covid vaccine on Monday 10/23/23.  The duplicate vaccine was discovered as the vaccine was documented this morning 10/26/23. Patient is doing fine showing no ill effects as of this report.  Facility was notified  and provider for patient at clinic was notified.
Age: 12.0
Sex: F
Vaccine: UNK
Symptoms: Extra dose administered
Clinical narrative: pt recieved a tdap on 7/17/23 and on 10/30/23  no harm done to pt
Age: 0.83
Sex: F
Vaccine: MMRV
Symptoms: No adverse event
Clinical narrative: There were no adverse events.
Age: 60.0
Sex: M
Vaccine: COVID19, FLU4, RSV, TDAP
Symptoms: Asthma, Chronic obstructive pulmonary disease, Condition aggravated, Cough, SARS-CoV-2 test negative
Clinical narrative: COPD/asthma Exacerbation. New deeper bronchial cough started about 10/22/1023. Consulted facility/Dr on 10/27. Saw Dr at Facility on 10/27 who diagnosed it as a COPD/asthma Exacerbation. He prescribed an antibiotic and Prednisone. This reduced the new cough by 10/30. The COPD breathing and cough symptoms persist at a level a little worse than previously.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Chills, Condition aggravated, Dyspnoea, Immunisation reaction
Clinical narrative: Patient received COVID-19 vaccine booster in his long term care residence in the SCI unit at Medical Center on 10/26. On 10/27 he was transferred to the ER for fevers, chills, injection site warmth/erythema and afib w/ RVR. Also with increased SOB which improved with suctioning. He was admitted to ICU and started on empiric antibiotics for c/f infection. Infectious workup negative and so antibiotics were discontinued on 10/30, symptoms were deemed more likely vaccine adverse effect. Transferred back to the SCI unit on 10/31.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth, Intensive care, Laboratory test normal, Oropharyngeal suctioning
Clinical narrative: Patient received COVID-19 vaccine booster in his long term care residence in the SCI unit at Medical Center on 10/26. On 10/27 he was transferred to the ER for fevers, chills, injection site warmth/erythema and afib w/ RVR. Also with increased SOB which improved with suctioning. He was admitted to ICU and started on empiric antibiotics for c/f infection. Infectious workup negative and so antibiotics were discontinued on 10/30, symptoms were deemed more likely vaccine adverse effect. Transferred back to the SCI unit on 10/31.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Patient received COVID-19 vaccine booster in his long term care residence in the SCI unit at Medical Center on 10/26. On 10/27 he was transferred to the ER for fevers, chills, injection site warmth/erythema and afib w/ RVR. Also with increased SOB which improved with suctioning. He was admitted to ICU and started on empiric antibiotics for c/f infection. Infectious workup negative and so antibiotics were discontinued on 10/30, symptoms were deemed more likely vaccine adverse effect. Transferred back to the SCI unit on 10/31.
Age: 74.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: none, patient received a second dose of the flu vaccine after recieving FLUAD on 09/19/2023
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Migraine
Clinical narrative: about 18 hours after getting the most recent spikevax vaccine I got a bad headache.  I get migraines routinely but this felt different than a migraine and was not accompanies by aura or light/sound sensitivity.  It lasted for about 24 hours and then I felt better.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Blood culture negative, COVID-19, Cachexia, Chest X-ray abnormal
Clinical narrative: Patient is a 81 y.o. male patient pmh adenocarcinoma of the lung, copd, pafib, htn who presents to ED with cough and abdominal pain.   Pneumonia of right lower lobe 2/2 COVID, Acute exacerbation of copd, acute pulmonary embolism without acute cor pulmonale- not seen on previous  Hemoptysis, persistent  COVID + on resp panel  Lactic acidosis on admission, resolved  CT chest showed small nonobstructive left lower lobe pulmonary embolism. No central emboli or cardiac strain. No PE found on repeat CT of chest.  Urine antigens and  MRSA probe negative BC x2 NGTD TTE LV segmental wall motion normal, EF- 62% Continue breathing treatments, duonebs scheduled, dulera. Acapella valve to assist with sputum production  Completed course of steroids  Day 8 of cefepime Multiple CXR show patchy right midlung infiltrate.  Continue O2 as increased work of breathing, wean as tolerated  Adjusted dose of xarelto after speaking with hematology on 10/6, lower dose to afib dosing instead of load for PE as CT showed no evidence of PE on repeat. However, after discussion with pulm on 10/8, will hold xarelto given persistent hemoptysis. Per pulm, hold AC until patient is seen by heme onc in clinic.    Lung adenocarcinoma He appears to be receiving radiation and tagrisso 80 daily is listed as a home med Held inpatient, will follow up outpatient  Will continue to hold until patient is seen in OP heme onc   Paroxysmal atrial fib Lopressor for rate control  Stop xarelto d/t continued hemoptysis    Essential htn Hold home meds at this time with borderline Bps  Diarrhea- resolved  Check Cdiff for completeness, negative 10/5   Cachexia Bmi 20
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Clostridium test negative, Computerised tomogram thorax abnormal, Condition aggravated, Cough
Clinical narrative: Patient is a 81 y.o. male patient pmh adenocarcinoma of the lung, copd, pafib, htn who presents to ED with cough and abdominal pain.   Pneumonia of right lower lobe 2/2 COVID, Acute exacerbation of copd, acute pulmonary embolism without acute cor pulmonale- not seen on previous  Hemoptysis, persistent  COVID + on resp panel  Lactic acidosis on admission, resolved  CT chest showed small nonobstructive left lower lobe pulmonary embolism. No central emboli or cardiac strain. No PE found on repeat CT of chest.  Urine antigens and  MRSA probe negative BC x2 NGTD TTE LV segmental wall motion normal, EF- 62% Continue breathing treatments, duonebs scheduled, dulera. Acapella valve to assist with sputum production  Completed course of steroids  Day 8 of cefepime Multiple CXR show patchy right midlung infiltrate.  Continue O2 as increased work of breathing, wean as tolerated  Adjusted dose of xarelto after speaking with hematology on 10/6, lower dose to afib dosing instead of load for PE as CT showed no evidence of PE on repeat. However, after discussion with pulm on 10/8, will hold xarelto given persistent hemoptysis. Per pulm, hold AC until patient is seen by heme onc in clinic.    Lung adenocarcinoma He appears to be receiving radiation and tagrisso 80 daily is listed as a home med Held inpatient, will follow up outpatient  Will continue to hold until patient is seen in OP heme onc   Paroxysmal atrial fib Lopressor for rate control  Stop xarelto d/t continued hemoptysis    Essential htn Hold home meds at this time with borderline Bps  Diarrhea- resolved  Check Cdiff for completeness, negative 10/5   Cachexia Bmi 20
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Echocardiogram, Echocardiogram normal, Haemoptysis
Clinical narrative: Patient is a 81 y.o. male patient pmh adenocarcinoma of the lung, copd, pafib, htn who presents to ED with cough and abdominal pain.   Pneumonia of right lower lobe 2/2 COVID, Acute exacerbation of copd, acute pulmonary embolism without acute cor pulmonale- not seen on previous  Hemoptysis, persistent  COVID + on resp panel  Lactic acidosis on admission, resolved  CT chest showed small nonobstructive left lower lobe pulmonary embolism. No central emboli or cardiac strain. No PE found on repeat CT of chest.  Urine antigens and  MRSA probe negative BC x2 NGTD TTE LV segmental wall motion normal, EF- 62% Continue breathing treatments, duonebs scheduled, dulera. Acapella valve to assist with sputum production  Completed course of steroids  Day 8 of cefepime Multiple CXR show patchy right midlung infiltrate.  Continue O2 as increased work of breathing, wean as tolerated  Adjusted dose of xarelto after speaking with hematology on 10/6, lower dose to afib dosing instead of load for PE as CT showed no evidence of PE on repeat. However, after discussion with pulm on 10/8, will hold xarelto given persistent hemoptysis. Per pulm, hold AC until patient is seen by heme onc in clinic.    Lung adenocarcinoma He appears to be receiving radiation and tagrisso 80 daily is listed as a home med Held inpatient, will follow up outpatient  Will continue to hold until patient is seen in OP heme onc   Paroxysmal atrial fib Lopressor for rate control  Stop xarelto d/t continued hemoptysis    Essential htn Hold home meds at this time with borderline Bps  Diarrhea- resolved  Check Cdiff for completeness, negative 10/5   Cachexia Bmi 20
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Lactic acidosis, Lung infiltration, Pneumonia, Pulmonary embolism, Radiotherapy
Clinical narrative: Patient is a 81 y.o. male patient pmh adenocarcinoma of the lung, copd, pafib, htn who presents to ED with cough and abdominal pain.   Pneumonia of right lower lobe 2/2 COVID, Acute exacerbation of copd, acute pulmonary embolism without acute cor pulmonale- not seen on previous  Hemoptysis, persistent  COVID + on resp panel  Lactic acidosis on admission, resolved  CT chest showed small nonobstructive left lower lobe pulmonary embolism. No central emboli or cardiac strain. No PE found on repeat CT of chest.  Urine antigens and  MRSA probe negative BC x2 NGTD TTE LV segmental wall motion normal, EF- 62% Continue breathing treatments, duonebs scheduled, dulera. Acapella valve to assist with sputum production  Completed course of steroids  Day 8 of cefepime Multiple CXR show patchy right midlung infiltrate.  Continue O2 as increased work of breathing, wean as tolerated  Adjusted dose of xarelto after speaking with hematology on 10/6, lower dose to afib dosing instead of load for PE as CT showed no evidence of PE on repeat. However, after discussion with pulm on 10/8, will hold xarelto given persistent hemoptysis. Per pulm, hold AC until patient is seen by heme onc in clinic.    Lung adenocarcinoma He appears to be receiving radiation and tagrisso 80 daily is listed as a home med Held inpatient, will follow up outpatient  Will continue to hold until patient is seen in OP heme onc   Paroxysmal atrial fib Lopressor for rate control  Stop xarelto d/t continued hemoptysis    Essential htn Hold home meds at this time with borderline Bps  Diarrhea- resolved  Check Cdiff for completeness, negative 10/5   Cachexia Bmi 20
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test positive, Staphylococcus test negative, Urine antigen test
Clinical narrative: Patient is a 81 y.o. male patient pmh adenocarcinoma of the lung, copd, pafib, htn who presents to ED with cough and abdominal pain.   Pneumonia of right lower lobe 2/2 COVID, Acute exacerbation of copd, acute pulmonary embolism without acute cor pulmonale- not seen on previous  Hemoptysis, persistent  COVID + on resp panel  Lactic acidosis on admission, resolved  CT chest showed small nonobstructive left lower lobe pulmonary embolism. No central emboli or cardiac strain. No PE found on repeat CT of chest.  Urine antigens and  MRSA probe negative BC x2 NGTD TTE LV segmental wall motion normal, EF- 62% Continue breathing treatments, duonebs scheduled, dulera. Acapella valve to assist with sputum production  Completed course of steroids  Day 8 of cefepime Multiple CXR show patchy right midlung infiltrate.  Continue O2 as increased work of breathing, wean as tolerated  Adjusted dose of xarelto after speaking with hematology on 10/6, lower dose to afib dosing instead of load for PE as CT showed no evidence of PE on repeat. However, after discussion with pulm on 10/8, will hold xarelto given persistent hemoptysis. Per pulm, hold AC until patient is seen by heme onc in clinic.    Lung adenocarcinoma He appears to be receiving radiation and tagrisso 80 daily is listed as a home med Held inpatient, will follow up outpatient  Will continue to hold until patient is seen in OP heme onc   Paroxysmal atrial fib Lopressor for rate control  Stop xarelto d/t continued hemoptysis    Essential htn Hold home meds at this time with borderline Bps  Diarrhea- resolved  Check Cdiff for completeness, negative 10/5   Cachexia Bmi 20
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: HAVING NUMBNESS AND TINGLING TO EXTREMETIES AND FROM BREAST DOWN TRUNK.  HAD SOLUMEDROL 500 MG IV X 1 WITH ONLY MINIMAL RELIEF OF SYMPTOMS.  WILL SEE MY NURSE PRACTITIONER TODAY AND REQUESTING REFERRAL TO NEUROLOGY
Age: 46.0
Sex: M
Vaccine: FLU4
Symptoms: Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: Patient called over 2 weeks later stating that he still cannot move his arm. He is having mobility issues and cannot fulfill daily tasks.
Age: 87.0
Sex: M
Vaccine: COVID19, FLU4, RSV
Symptoms: Aphasia, Blood test, Cardiac monitoring abnormal, Cerebrovascular accident, Chest discomfort
Clinical narrative: He got his vaccines, the followoing day he had a sore arm.  The next day he was driving his car and he knew somethign was wrong.  He came to a rotary and did not go around it and went over it.  He did not hit anything, knew that he was in trouble.  He went to a gas station and got half out of the car, and grabbed the steering wheel and could not move his arm.  Attendend asked him if he was OK and he could not answer, he called 911 and he was taken to the hospital by ambulance.  He went to Hospital.  Once he got to the ER in about 3 hours he could speak and he could move his arm.  They informed him that he had had a stroke.  He was admitted to the hospital, and was there for 4 days.  He did have blood work, MRI's and CAT scans.  He was put on Plavix for 21 days and then they wanted him to wear a heart monitor for 30 days, but he was going to travel in 20 days and he was told to see his cardiologist and he was put on a 14 day heart monitor and still has 6 days to go with the heart monitor.  He is feeling tired at this point, more tired than he usually is.  He did have some chest discomfort that is recorded on the event monitor that he is wearing.